ErVimmune
28 RUE LAENNEC
69008 LYON
FRANCE
About ErVimmune
Medical research and development, in particular the development of new families of tumour antigens.
Research, development and production of monoclonal antibodies and derivatives targeting new membrane antigens and any other activity of any nature whatsoever related to the biotechnology and/or pharmaceutical industry.
Useful links
> Publications & abstracts
> Recent news
> Legal notice
Navigation
> Home
> About us
> Sciences
> Investors
> Join us
> Contact
Contact
28 RUE LAENNEC
69008
LYON FRANCE
contact@ervimmune.com
+33 6 67 67 44 97
© 2023 ErVimmune | Next Generation Cancer Immunotherapies | Design by om&go